EP Patent

EP2274617A4 — METHODS FOR IDENTIFYING AND USING AGENTS TARGETING CANCER STEM CELLS

Assigned to Massachusetts Institute of Technology · Expires 2011-11-09 · 15y expired

What this patent protects

Patent listed against defibrotide-sodium.

Drugs covered by this patent

defibrotide-sodium (DEFIBROTIDE SODIUM)

Patent Metadata

Patent number: EP2274617A4
Jurisdiction: EP
Classification: —
Expires: 2011-11-09
Drug substance claim: No
Drug product claim: No
Assignee: Massachusetts Institute of Technology
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.